ABVC BIOPHARMA, INC.
ABVCNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ABVC. That does not mean none is planned.
Get an email about ABVC's next catalysts
Track ABVC BIOPHARMA (ABVC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
ABVC Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PDC-1421 Capsule | Phase 2 | Attention-Deficit Hyperactivity Disorder (ADHD) | - | - |
Frequently asked questions
What is in ABVC BIOPHARMA, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in ABVC BIOPHARMA, INC.'s (ABVC) pipeline across Phase 2. Its lead program is PDC-1421 Capsule (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ABVC BIOPHARMA, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ABVC BIOPHARMA, INC. (ABVC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ABVC biotech catalysts?→
Add ABVC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ABVC BIOPHARMA, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.